BPH symptom registry for people needing treatment
Part of Kidney & urinary clinical trials.
This trial is a global registry that collects information about people with an enlarged prostate (BPH) who have urinary symptoms and are receiving treatment. It may help researchers better understand which treatments work best and how symptoms change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a primary diagnosis of BPH (enlarged prostate).
- You have urinary symptoms from BPH (LUTS), not just an enlarged prostate by itself.
- You are currently on medication for BPH or have been advised to have a procedure/surgery for BPH.
- You should have an active plan to treat your BPH symptoms (medicines or surgery).
- You should not be in the study if your BPH has no symptoms and you feel fine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a study registry that collects information from men who are going to receive TULSA-PRO treatment. It helps researchers understand how the treatment is used and what outcomes people experience.
This trial collects information from people being treated for enlarged prostate (BPH) and related urinary symptoms to evaluate how well treatments work and how safe they are. It may help improve future care by better tracking real-world outcomes.
This trial is for people with enlarged prostate (benign prostatic hyperplasia) who are already on medication or have had surgery. It aims to understand how well treatments work and how they affect quality of life.
This study is a European registry tracking how a laser treatment (TPLA) helps men with an enlarged prostate and bothersome urinary symptoms. It aims to see how safe and effective this new procedure is for daily life.
This study tests a better way to manage benign prostatic hyperplasia (BPH) by using your answers to regular health questionnaires. It may help your care team make more informed decisions about your symptoms and treatment over time.
This study is for men with moderate to severe BPH symptoms who haven't responded well to one medicine alone. It tests a combination of two drugs (solifenacin and tamsulosin) to see if they improve symptom control and quality of life.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.